Komen leadership in flux

Earlier today (Wednesday, Aug. 8, 2012) Komen President Liz Thompson announced her plans to leave Susan G. Komen for the Cure next month. Founder Nancy Brinker will also give up her role as Komen CEO and serve as chair of the board as soon as a replacement is found, and two board members are stepping down, Brenda Lauderback and Linda Law.

The news comes exactly one week after Komen was criticized once again in a key public forum, this time by MDs who called out the organization for the exaggeration and distortion of medical information in its 2011 advertising campaigns about the benefits of screening mammography. The authors of the British Medical Journal, Steven Woloshin, MD, and Lisa M. Schwartz, MD, pointed out fallacies and exaggerations in Komen’s advertising and argued that “Women need much more than marketing slogans about screening: they need –and deserve–the facts.”

The fact is, this was not the first time Komen was criticized for failing to provide accurate and useful health information to improve the lives of those living with, and at risk for, breast cancer. The organization has also been denounced for overzealousness in protecting its trademarks, reducing its research allocations despite record revenues, profiting from a disease in the name of its cure, and putting corporate and political agendas in the way of patients’ rights and access to quality care.

In February of 2012 Komen’s decision to cut ties with Planned Parenthood (and then the semi-reversal of that decision following public outcry), sent the organization into a frenzied state of damage control. Attendance at Komen events declined. Donations dropped. Komen immediately sought advice from a former White House press secretary in the George W. Bush administration, Ari Fleischer, and hired a consulting firm founded by former Democratic pollsters to assess Komen’s reputation and identify the type of “apology” that would be most helpful for restoring credibility.

Komen founder Nancy Brinker apologized to Planned Parenthood, Congress, the public, and to Komen affiliates on behalf of the organization, but the vague “mistakes were made . . . we’ve learned a lot . . . let’s heal and get past this” storyline didn’t ring true. Eve Ellis, who served on Komen’s New York affiliate board for six years and raised over $250,000 for the group, publicly rebuffed Brinker’s apology. She said in an open letter that Brinker needed to take some “truth serum.” From Ellis’s experience, she did not believe Komen’s Planned Parenthood decision was apolitical, and she said the only way she would consider supporting the charity again would be for the organization to clean house, starting with the resignations of Nancy Brinker and the entire board of directors.

A petition on www.change.org reiterated Ellis’s statement and the growing sentiment that Komen’s top leadership needed to go, citing “abuses of the public trust and failures of corporate governance (such as hiring Karen Handel to be vice president of public affairs knowing that she had run for governor of Georgia on a platform to defund Planned Parenthood; deceiving the public about the decision-making process that led to the defunding of Planned Parenthood; and misrepresenting to the public that reaction to the defunding decision, thus failing to disclose the true condition of the organization.) These failures were attributed to the leadership of Brinker and entire the board of directors. The petition, which had more than 2,000 signatures by the end of April 2012, not only called for the immediate resignations of Brinker and the board but also recommended a strong process for vetting replacement nominations that would involve all of Komen’s affiliates.

The managing director of the grants program, Mollie Williams, resigned in protest quickly after the board’s initial decision to defund Planned Parenthood. Not long after that, five executives from the national headquarters resigned, including the executive vice president and chief marketing officer, the vice president for global networks, the vice president of communications, a director for affiliate strategy and planning, and the organization’s chief fundraiser. Komen’s chairman of the board also stepped down as did Nancy Brinker’s son, Eric Brinker. Despite the shuffling, Nancy Brinker refused to leave her post and the Komen board cited full confidence in her leadership.

If Komen is really cleaning house, the organization would be wise to address the serious criticisms it has faced in the last several years, with transparency and accountability. It would benefit from charting a new direction to avoid conflicts of interest and threats to public health and to the public good. It would listen to the people on the ground who are working in their communities to fill gaps in care, include the affiliate organizations in decision making, change the conversation about breast cancer, and take action against the systemic factors that continue to impede progress in eradicating the epidemic.

Is the shuffle too little too late?



A version of this article appeared (Aug. 9, 2012) on the Oxford University Press Blog; on the Ms. Magazine Blog (Aug. 9, 2012); and was translated into Italian by Grazia De Michele (Aug. 13, 2012) on L’Amazzone Furiosa.



Be Sociable, Share!

8 comments to Komen leadership in flux

  • BlondeAmbition

    Another superb and thorough piece, Gayle! While this certainly feels like a step in the right direction, I have to agree that I’m not sure whether it is enough. Brinker is beyond tainted at this point and even if she is removed from day-to-day management, it raises the concern that she will be traveling the globe (as is suggested by her new role) on extravagant excursions — all in the name of ‘awareness’ — on Komen’s dime.

    Time will tell whether this is a nail in the pink coffin or simply window dressing and a rearrangement of the pink deck shares on the SS T̶i̶t̶a̶n̶i̶c̶ Komen.

  • Gayle,

    As always, a brilliant post sticking to reason supported by facts. I like to believe it’s never too late to make apologies, change direction, get refocused or whatever one wants to call it.

    There has been a lot of shuffling going on of late that’s for sure. Is it too little too late? Who knows. One thing the Komen organization surely does know now is that more eyes are watching.

  • Right, Nancy, the whole world is watching. Brinker is shifting back to chair the board, so she’ll still be steering that ship. Will the top heavy organization be able to turn around to make up for past mistakes and, importantly, chart a new path that will make a real difference in breast cancer? An unknown. There are numerous organizations willing to take up the slack. I think it’s time we let them. I think you’re also correct @BlondeAmbition that Brinker herself has tainted the organization. She’d do more for them if she got out of the picture altogether. Not likely. This is her baby.

  • Thanks for a wonderful synopsis, Gayle.

    The implosion is well underway. Komen’s words and actions are going in opposite directions. The critical question to me?
    is Nancy Brinker still relevant to breast cancer research and treatment? Is she relevant to what some of us believe needs to happen to accelerate significant progress in developing effective treatments and true prevention?

    No.

    Let’s get busy.
    jms

  • Is Brinker still relevant?? Excellent question, Jody. I imagine she’s still relevant to Komen, and will continue to be as she serves as the board’s executive chair, but is she relevant to breast cancer research and treatment? That tide seems to be turning, and Komen has been behind the times on that front for awhile with the overfocus on screening, declining research funds, and overfocus on branding. Your question requires deep contemplation on the part of ALL players in the breast cancer world.

  • I believe the shuffle is a bit too late. Why Ms. Brinker herself won’t step down is beyond me. Some people epitomize pride and arrogance, and she is one of them. Thanks for this great expose. We must keep up the journalistic pressure to get organizations to see the light, a light not cast in pink. xx

  • You have to wonder when Eve Ellis, an ex-board member of Komen New York City, openly writes to friends, family, and the press calling for Nancy Brinker’s resignation and everyone around Nancy Brinker is leaving the organization, why she doesn’t see she has lost the public’s trust. It’s like Rome is burning and Nero is playing his(or her) fiddle. Her ridiculous apology over the Planned Parenthood debacle was clearly unapologetic. I also went back and reviewed her pinkwashing items at:
    http://www.guardian.co.uk/world/gallery/2012/feb/15/pinkwashing-breast-health-komen?intcmp=239#/?picture=385987915&index=0
    and it really gets me mad knowing that every 14 minutes there is another woman in the USA dying of breast cancer. These are real people’s lives. Nancy Brinker wake up!
    I feel awful for so many people who blindly raced, gave , and hoped for “the cure” and I wonder, where do we go from here? We can’t afford to have people completely distrust breast cancer advocacy because of Nancy Brinker’s ego. Thanks Gayle for continuing to share this information with us.-Susan

  • Definitely too little, too late. As always, an excellent, thought-provoking post on a major exploiter of breast cancer and women.

Leave a Reply

 

 

 

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

“Pink Ribbon Blues,” Book

Paperback includes new Introduction on fundraising controversies and color insert with images of, and reactions to, the pinking of breast cancer (2012).


Order the Paperback » 


Read Reviews » 


More »


Recent Sulik Interviews

A Year After Bombings, Some Say 'Boston Strong' Has Gone Overboard NPR, All Things Considered

Canadian Mammogram Study KCRW, NPR Affiliate

Breast Cancer: Awareness, Activism & Pinkwashing NPR Charlotte

Buying Pink Al Jazeera's The Stream Watch »

The Pink Backlash Orlando Sentinel

Preventative Mastectomies: Disease and Deception Listen to BlogTalkRadio »

Angelina Jolie and the 'Breast Cancer Gene' Listen to KCRW »

Our Feel-Good War on Breast Cancer. The New York Times Magazine.

The Story Behind the Pink Ribbon Campaign Sisters Talk Radio

WISH Interview Women's International Summit for Health

Making Cancer About The Patient, Not The Body Part CBS Pittsburgh

Sexy breast cancer campaigns anger many patients USA Today

The perils of pink The Daily

Komen pink campaign creates breast-cancer blues for some Dallas Morning News

A yellow flag for the NFL's pink New York Daily

Gayle Sulik named #7 in SharecareNow’s Top 10 Online Influencers in Breast Cancer

"Breast cancer cancer causes so easily derailed" Philly Inquirer

"Komen Charity Under Microscope for Funding, Science" Reuters

"The Fight Against Cancer - And Abortion? Salon.com

"Susan G. Komen For the Cure defunds Planned Parenthood." In Deep with Angie Coiro

"Amid Breast Cancer Month, Is there Pink Fatigue?" NPR's All Things Considered

"How is Breast Cancer Culture Undermining Women's Health?" America’s Radio News Network

"Pink Ribbon Culture and Breast Cancer" The Kojo Nnamdi Show

"The Big Business of Breast Cancer" 
Marie Claire

"Does Breast Cancer Awareness Month Crowd Out Other Diseases?" Slate

"Pink Inc. Has Many Starting to See Red" The Sacramento Bee

"Get Your Pink Off" Ottawa Citizen

"Komen Pink Ribbons Raise Green and Questions" USA Today

** MORE MEDIA LINKS **
** MORE RADIO INTERVIEWS **